Analystreport

Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at Goldman Sachs Group Inc from a "buy" rating to a "conviction-buy" rating.

Bio-Rad Laboratories, Inc. Class A  (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report